Parker H E, Habib A M, Rogers G J, Gribble F M, Reimann F
Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.
Diabetologia. 2009 Feb;52(2):289-298. doi: 10.1007/s00125-008-1202-x. Epub 2008 Dec 11.
AIMS/HYPOTHESIS: Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone with anti-apoptotic effects on the pancreatic beta cell. The aim of this study was to generate transgenic mice with fluorescently labelled GIP-secreting K cells and to use these to investigate pathways by which K cells detect nutrients.
Transgenic mice were generated in which the GIP promoter drives the expression of the yellow fluorescent protein Venus. Fluorescent cells were purified by flow cytometry and analysed by quantitative RT-PCR. GIP secretion was assayed in primary cultures of small intestine.
Expression of Venus in transgenic mice was restricted to K cells, as assessed by immunofluorescence and measurements of the Gip mRNA and GIP protein contents of purified cells. K cells expressed high levels of mRNA for Kir6.2 (also known as Kcnj11), Sur1 (also known as Abcc8), Sglt1 (also known as Slc5a1), and of the G-protein-coupled lipid receptors Gpr40 (also known as Ffar1), Gpr119 and Gpr120. In primary cultures, GIP release was stimulated by glucose, glutamine and linoleic acid, and potentiated by forskolin plus 3-isobutyl-1-methylxanthine (IBMX), but was unaffected by the artificial sweetener sucralose. Secretion was half-maximal at 0.6 mmol/l glucose and partially mimicked by alpha-methylglucopyranoside, suggesting the involvement of SGLT1. Tolbutamide triggered secretion under basal conditions, whereas diazoxide suppressed responses in forskolin/IBMX.
CONCLUSIONS/INTERPRETATION: These transgenic mice and primary culture techniques provide novel opportunities to interrogate the mechanisms of GIP secretion. Glucose-triggered GIP secretion was SGLT1-dependent and modulated by K(ATP) channel activity but not determined by sweet taste receptors. Synergistic stimulation by elevated cAMP and glucose suggests that targeting appropriate G-protein-coupled receptors may provide opportunities to modulate GIP release in vivo.
目的/假设:葡萄糖依赖性促胰岛素多肽(GIP)是一种肠促胰岛素激素,对胰腺β细胞具有抗凋亡作用。本研究的目的是生成具有荧光标记的分泌GIP的K细胞的转基因小鼠,并利用这些小鼠研究K细胞检测营养物质的途径。
生成转基因小鼠,其中GIP启动子驱动黄色荧光蛋白Venus的表达。通过流式细胞术纯化荧光细胞,并通过定量逆转录聚合酶链反应进行分析。在小肠原代培养物中测定GIP分泌。
通过免疫荧光以及对纯化细胞中Gip mRNA和GIP蛋白含量的测量评估,转基因小鼠中Venus的表达仅限于K细胞。K细胞表达高水平的Kir6.2(也称为Kcnj11)、Sur1(也称为Abcc8)、Sglt1(也称为Slc5a1)的mRNA,以及G蛋白偶联脂质受体Gpr40(也称为Ffar1)、Gpr119和Gpr120。在原代培养物中,葡萄糖、谷氨酰胺和亚油酸刺激GIP释放,福斯可林加3 - 异丁基 - 1 - 甲基黄嘌呤(IBMX)增强GIP释放,但人工甜味剂三氯蔗糖对其无影响。在0.6 mmol/l葡萄糖时分泌达到半最大,α - 甲基吡喃葡萄糖苷可部分模拟该作用,提示SGLT1参与其中。甲苯磺丁脲在基础条件下触发分泌,而二氮嗪抑制福斯可林/IBMX刺激的反应。
结论/解读:这些转基因小鼠和原代培养技术为探究GIP分泌机制提供了新的机会。葡萄糖触发的GIP分泌依赖于SGLT1,并受K(ATP)通道活性调节,但不由甜味受体决定。cAMP升高与葡萄糖的协同刺激表明,靶向合适的G蛋白偶联受体可能为体内调节GIP释放提供机会。